FDA PMA FDA Class 3 Approved 🇺🇸 United States

Drug Eluting Permanent Left Ventricular (Lv) Pacemaker Electrode

PMA: P060039 · Supplement: S083 · Decision Mar 15, 2018
Classifications
1
FEI Numbers
22
Registration Numbers
22

Basic Information

Device Name
Drug Eluting Permanent Left Ventricular (Lv) Pacemaker Electrode
Trade Name
Attain StarFix Model 4195 Lead
PMA Number
P060039
Supplement Number
S083
Device Class
FDA Class 3
Product Code
OJX
Generic Name
Drug eluting permanent left ventricular (lv) pacemaker electrode
Medical Specialty
Unknown
Advisory Committee
Cardiovascular
Decision
Approved
Decision Code
APPR
Decision Date
March 15, 2018
Date Received
January 26, 2018
Supplement Type
Normal 180 Day Track No User Fee
Supplement Reason
Labeling Change - PAS
Expedited Review
N

Advisory Committee Statement

Approval for an update to the labeling to include a summary of the Attain StarFix Model 4195 Lead Chronic Performance Study data.

Classifications

This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.

Product Code Device Name
OJX Drug Eluting Permanent Left Ventricular (Lv) Pacemaker Electrode